Zoetis
Trade Zoetis 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ZTS
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments.
ZTS Key Statistics
Stock Snapshot
Zoetis(ZTS) stock is priced at $75.07, giving the company a market capitalization of 31.16B. It carries a P/E multiple of 12.75 and pays a dividend yield of 2.7%.
On 2026-05-14, Zoetis(ZTS) stock traded between a low of $74.90 and a high of $75.19. Shares are currently priced at $75.07, which is +0.2% above the low and -0.2% below the high.
The Zoetis(ZTS)'s current trading volume is 174.31K, compared to an average daily volume of 11.36M.
During the past year, Zoetis(ZTS) stock moved between $74.29 at its lowest and $172.23 at its peak.
During the past year, Zoetis(ZTS) stock moved between $74.29 at its lowest and $172.23 at its peak.
ZTS News
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Zoetis is now the #5 analyst pick, mo...
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Zoetis Inc (Symbol: ZTS) has taken over the #133 sp...
Zoetis (ZTS) is back in focus after its rare Q1 2026 miss on both revenue and earnings, a lowered full year outlook, and a sharp slide in the share price. The...
Analyst ratings
68%
of 22 ratingsMore ZTS News
In early May 2026, Zoetis Inc. reported first-quarter sales of US$2,262 million, essentially flat net income year on year, and lowered its full-year 2026 revenu...
Wall Street's momentum trade turned brutal for several large-cap names last week as weak earnings, cautious guidance and analyst downgrades sparked heavy sellin...
UBS lowered the firm’s price target on Zoetis (ZTS) to $99 from $130 and keeps a Neutral rating on the shares. Unlock hedge fund-level data and powerful invest...
Zoetis (NYSE:ZTS) has cut its full year guidance after a sharp downturn in its U.S. companion animal business. Management points to higher price sensitivity am...
Zoetis ((ZTS)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and powerful inve...
Futures are higher this morning, helped by another sharp decline in oil prices on optimism around a potential U.S.-Iran framework agreement. Crude dropping back...
Key Points Zoetis delivered sales and adjusted earnings per share growth of 3% and 9%, which was below analysts' expectations. Worse yet, its guidance for 202...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.